Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development, as well as sharply reducing the enormous cost and time to bring effective treatments to millions of patients. AT leverages over 20 years of international genomics research, pioneering a novel approach to guide its drug development. The company collaborates closely with The Center for Applied Genomics (CAG) at the Childrens Hospital of Philadelphia to repurpose and develop ground-breaking new medical treatments. AT-001, ATs Alzheimers drug candidate, has the potential to become the first cure for dementia, not only treating the disease but preventing...

Drug discovery,genealogical database,precision-based drug development,diagnostic testing,genetic information,and therapeutic development

Arctic therapeutics operates in the Pharmaceutical manufacturing industry.

Arctic therapeutics's revenue is 11m - 100m

Arctic therapeutics has 11 - 50 employees.